Trial · NCT01470248
Adverse events18
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 18 of 18
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dyspnea | Respiratory, thoracic and mediastinal disorders | Arsenic Trioxide Treatment | 1 | 19 | |
| other | Anemia | Blood and lymphatic system disorders | Arsenic Trioxide Treatment | 1 | 19 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Arsenic Trioxide Treatment | 1 | 19 | |
| other | Elevated creatinine | Renal and urinary disorders | Arsenic Trioxide Treatment | 1 | 19 | |
| other | Facial edema around eyes | Skin and subcutaneous tissue disorders | Arsenic Trioxide Treatment | 1 | 19 | |
| other | Generalized weakness | General disorders | Arsenic Trioxide Treatment | 1 | 19 | |
| other | Hyperbilirubinemia | Blood and lymphatic system disorders | Arsenic Trioxide Treatment | 2 | 19 | |
| other | Hyperglycemia | Metabolism and nutrition disorders | Arsenic Trioxide Treatment | 1 | 19 | |
| other | Hypoalbuminemia | Blood and lymphatic system disorders | Arsenic Trioxide Treatment | 3 | 19 | |
| other | Hypocalcemia | Blood and lymphatic system disorders | Arsenic Trioxide Treatment | 1 | 19 | |
| other | Hyponatremia | Blood and lymphatic system disorders | Arsenic Trioxide Treatment | 1 | 19 | |
| other | Hypophosphatemia | Blood and lymphatic system disorders | Arsenic Trioxide Treatment | 1 | 19 | |
| other | Increased alkaline phosphatase | Blood and lymphatic system disorders | Arsenic Trioxide Treatment | 1 | 19 | |
| other | Increased lipase | Blood and lymphatic system disorders | Arsenic Trioxide Treatment | 1 | 19 | |
| other | Leukopenia | Blood and lymphatic system disorders | Arsenic Trioxide Treatment | 2 | 19 | |
| other | Neutrophil count decreased | Blood and lymphatic system disorders | Arsenic Trioxide Treatment | 1 | 19 | |
| other | Hyperbilirubinemia | Blood and lymphatic system disorders | Arsenic Trioxide Treatment | 1 | 19 | |
| serious | Pleural effusion | Respiratory, thoracic and mediastinal disorders | Arsenic Trioxide Treatment | 1 | 19 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01470248/events